Related Experiment Video
Updated: Mar 6, 2026

05:54
Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
2.1K
NETosis in Alzheimer's Disease
Enrica Caterina Pietronigro1, Vittorina Della Bianca1, Elena Zenaro1
1Department of Medicine, Section of General Pathology, University of Verona , Verona , Italy.
Frontiers in Immunology
|March 18, 2017
Summary
Neutrophils and their extracellular traps (NETs) contribute to Alzheimer's disease (AD) pathology by damaging brain tissue. Targeting NETs may offer a new therapeutic strategy for AD treatment.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder marked by cognitive decline, amyloid-β plaques, neurofibrillary tangles, and neuroinflammation.
- Neuroinflammation is a key feature of AD, and understanding its mechanisms is crucial for developing new treatments.
- Recent research indicates neutrophils infiltrate the brain in AD, suggesting a role in disease pathogenesis.
Purpose of the Study:
- To investigate the role of neutrophils and neutrophil extracellular traps (NETs) in Alzheimer's disease pathogenesis.
- To explore the potential of targeting neutrophils and NETs as a therapeutic strategy for AD.
Main Methods:
- Studies in transgenic AD mouse models and human AD subjects.
- Observation of neutrophil adhesion, migration, and NET formation within brain vasculature and parenchyma.
- Assessment of therapeutic effects of neutrophil depletion and LFA-1 integrin inhibition in AD mouse models.
- Confocal microscopy to confirm the presence of NETs in human AD brain tissue.
Main Results:
- Neutrophils were observed adhering to and migrating within brain blood vessels and parenchyma in both AD mouse models and human subjects.
- Neutrophil depletion and LFA-1 inhibition in AD mice reduced memory loss and neuropathological AD features.
- Neutrophil extracellular traps (NETs) were found within blood vessels and parenchyma in AD mice and human subjects, indicating their presence and potential role in tissue damage.
- NETs may exacerbate neuroinflammation and contribute to vascular and parenchymal damage in AD.
Conclusions:
- Neutrophils and NETs play a significant role in the neuropathological destruction associated with Alzheimer's disease.
- Targeting NET formation presents a promising novel therapeutic approach to delay AD progression and treat the disease.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K

